메뉴 건너뛰기




Volumn 31, Issue 3, 2013, Pages 458-462

Long-term control of non-infectious paediatric panuveitis refractory to traditional immunesuppressive therapy successfully treated with adalimumab (Humira™)

Author keywords

Adalimumab; Immunesuppression; Paediatric; Uveitis

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

EID: 84878355555     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (16)
  • 1
    • 8644266097 scopus 로고    scopus 로고
    • Paediatric uveitis: a Sydney clinic experience
    • AZAR D, MARTIN F: Paediatric uveitis: a Sydney clinic experience. Clin Experiment Ophthalmol 2004; 32: 468-71.
    • (2004) Clin Experiment Ophthalmol , vol.32 , pp. 468-471
    • Azar, D.1    Martin, F.2
  • 2
    • 0031846048 scopus 로고    scopus 로고
    • Cyclosporin A therapy in refractory non-infectious childhood uveitis
    • KILMARTIN DJ, FORRESTER JV, DICK AD: Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998; 82: 737-42.
    • (1998) Br J Ophthalmol , vol.82 , pp. 737-742
    • Kilmartin, D.J.1    Forrester, J.V.2    Dick, A.D.3
  • 4
    • 0022641533 scopus 로고
    • T cell lines mediatine experimental autoimmune uveoretinitis (EAU) in the rat
    • CASPI RR, ROBERGE FG, MCALLISTER CG et al.: T cell lines mediatine experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986; 136: 928-33.
    • (1986) J Immunol , vol.136 , pp. 928-933
    • Caspi, R.R.1    Roberge, F.G.2    Mcallister, C.G.3
  • 5
    • 0028113112 scopus 로고
    • The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice
    • NAKAMURA S, YAMAKAWA T, SUGITA M et al.: The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci 1994; 35: 3884-9.
    • (1994) Invest Ophthalmol Vis Sci , vol.35 , pp. 3884-3889
    • Nakamura, S.1    Yamakawa, T.2    Sugita, M.3
  • 6
    • 78449267111 scopus 로고    scopus 로고
    • The effects of Adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients
    • YUE C, YOU X, ZHAO L et al.: The effects of Adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol Int 2010; 30: 1553-7.
    • (2010) Rheumatol Int , vol.30 , pp. 1553-1557
    • Yue, C.1    You, X.2    Zhao, L.3
  • 7
    • 66149125235 scopus 로고    scopus 로고
    • Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with Adalimumab for active ankylosing spondylitis
    • RUDWALEIT M, CLAUDEPIERRE P, WORDSWORTH P et al.: Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with Adalimumab for active ankylosing spondylitis. J Rheumatol 2009; 36: 801-8.
    • (2009) J Rheumatol , vol.36 , pp. 801-808
    • Rudwaleit, M.1    Claudepierre, P.2    Wordsworth, P.3
  • 8
    • 75749091855 scopus 로고    scopus 로고
    • Effectiveness of Adalimumab in treating patients with active psoriatic arthritis (PsA) and predictors of good clinical responses for arthritis, skin, and nail lesions
    • VAN DEN BOSCH F, MANGER B, GOUPILLE P et al.: Effectiveness of Adalimumab in treating patients with active psoriatic arthritis (PsA) and predictors of good clinical responses for arthritis, skin, and nail lesions. Ann Rheum Dis 2010; 69: 394-9.
    • (2010) Ann Rheum Dis , vol.69 , pp. 394-399
    • Van Den Bosch, F.1    Manger, B.2    Goupille, P.3
  • 9
    • 0028336634 scopus 로고
    • Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat
    • DE VOS AF, VAN HAREN MAC, VERHAGEN C: Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994; 35: 1100-6.
    • (1994) Invest Ophthalmol Vis Sci , vol.35 , pp. 1100-1106
    • De Vos, A.F.1    Van Haren, M.A.C.2    Verhagen, C.3
  • 10
    • 34250366261 scopus 로고    scopus 로고
    • Adalimumab for sight-threatening uveitis in Behçet's disease
    • MUSHTAQ B, SAEED T, SITUNAYAKE RD, MURRAY PI: Adalimumab for sight-threatening uveitis in Behçet's disease. Eye (Lond) 2007; 21: 824-5.
    • (2007) Eye (Lond) , vol.21 , pp. 824-825
    • Mushtaq, B.1    Saeed, T.2    Situnayake, R.D.3    Murray, P.I.4
  • 13
    • 33947581722 scopus 로고    scopus 로고
    • Adalimumab in the therapy of uveitis in childhood
    • BIESTER S, DEUTER C, MICHELS H et al.: Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007; 91: 319- 24.
    • (2007) Br J Ophthalmol , vol.91 , pp. 319-324
    • Biester, S.1    Deuter, C.2    Michels, H.3
  • 14
    • 80855165266 scopus 로고    scopus 로고
    • Efficacy of switching to Adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab
    • LECCESE P, LATANZA L, D'ANGELO S, PADULA A, OLIVIERI I: Efficacy of switching to Adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Clin Exp Rheumatol 2011; 29 (Suppl. 67): S93.
    • (2011) Clin Exp Rheumatol , vol.29 , Issue.SUPPL. 67
    • Leccese, P.1    Latanza, L.2    D'Angelo, S.3    Padula, A.4    Olivieri, I.5
  • 15
    • 80855144525 scopus 로고    scopus 로고
    • Efficacy of Adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab
    • OLIVIERI I, LECCESE P, D'ANGELO S et al.: Efficacy of Adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. Clin Exp Rheumatol 2011; 29 (Suppl. 67): S54-7.
    • (2011) Clin Exp Rheumatol , vol.29 , Issue.SUPPL. 67
    • Olivieri, I.1    Leccese, P.2    D'Angelo, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.